Physician profile
Eva S Arkin
NPI 1558356147
$5,340.48
in general payments reported to CMS, 2019-2025
35 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $503 · 2021: $1,110 · 2022: $1,047 · 2023: $750 · 2024: $550 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,679.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $930.14 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $664.97 | 2019-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $567.96 | 2019-2022 | |
| Pfizer INC. | $425.77 | 2020-2024 | |
| Astellas Pharma Global Development | $384.24 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $254.37 | 2021-2025 | |
| Novo Nordisk INC | $203.11 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $194.88 | 2019-2025 | |
| Aspira Women'S Health INC | $191.51 | 2021 | |
| Myovant Sciences INC. | $173.15 | 2021-2022 | |
| Bausch Health US, LLC | $165.41 | 2019-2024 | Wellbutrin, Aplenzin |
| Gynesonics, INC. | $160.13 | 2022 | |
| Avion Pharmaceuticals | $147.92 | 2019-2023 | Balcoltra |
| Amgen INC. | $73.98 | 2019-2024 | Prolia, Evenity |
| Sumitomo Pharma America, INC. | $68.11 | 2023-2024 | Myfembree |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $66.84 | 2019 | |
| Exeltis, USA INC. | $57.46 | 2019-2024 | Slynd |
| Millicent US INC | $54.75 | 2021-2025 | Femlyv, Intrarosa |
| Allergan, INC. | $54.15 | 2019-2020 | |
| Evofem Biosciences, INC. | $53.70 | 2021-2024 | Phexxi |
| Amag Pharmaceuticals, INC. | $53.18 | 2019 | |
| Hologic Sales and Service, LLC | $49.10 | 2019-2024 | Aptima |
| Nalpropion Pharmaceuticals LLC | $37.71 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $35.00 | 2021 | |
| Agile Therapeutics, INC. | $34.42 | 2022-2024 | Twirla |
| Lupin INC. | $33.00 | 2019-2020 | |
| Medtronic, INC. | $31.77 | 2025 | Altaviva |
| Ascend Therapeutics US, LLC | $30.31 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $28.38 | 2019-2020 | |
| Impel Pharmaceuticals INC. | $23.48 | 2023 | Trudhesa |
| Exact Sciences Corporation | $21.56 | 2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $20.62 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $19.21 | 2019 | |
| Lilly USA, LLC | $16.95 | 2024 | Zepbound |
| Covidien LP | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Arkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.